AstraZeneca Eyes Full U.S. Approval For Covid Shot This Year, Skipping Faster Emergency Authorization

The company previously indicated it would pursue an emergency use authorization but has struggled to meet the U.S. regulator's demand for data.

Source: Forbes.com Healthcare News - July 29, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Editors' Pick editors-pick Coronavirus Source Type: news